 Treatment of locally advanced and metastatic squamous cell carcinoma of the lung involves the use of chemotherapy as the therapeutic mainstay. Platinum-etoposide regimens such as cisplatin-etoposide are the most commonly used chemotherapeutic regimen, which is delivered intravenously in the standard three-weekly intervals. 